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T he incidence of renal cell cancer (RCC) in renal allografts is as low as 0.3% [1].  Nephron-sparing 
surgery is ideal for excising these tumors,  whereas par-
tial nephrectomy of a renal allograft is technically chal-
lenging.  Cryoablation is a new treatment option to treat 
small-sized RCCs.  We report a case of RCC in a kidney 
allograft treated by cryoablation.  To our knowledge,  
this is the first case in Asia and ninth case worldwide of 
RCC in a kidney allograft treated with cyroablation.
Case Presentation
A 49-year-old man was diagnosed with nephroscle-
rosis by renal biopsy in 2006.  His renal function gradu-
ally deteriorated,  and he received hemodialysis from 
2011 to 2012.  He then underwent a living renal trans-
plant from his younger brother’s left renal for end-stage 
renal disease (ESRD) at another hospital.  His family 
showed no history of renal cancer.  The postoperative 
immunosuppression regimen consisted of tacrolimus,  
mycophenolate mofetil,  and prednisolone.  Renal func-
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Nephron-sparing treatment should be offered whenever possible to avoid dialysis in allograph cases.  
Cryoablation is a new treatment option for treating small-sized renal cell cancer (RCCs).  We report a case of 
RCC arising in a kidney allograft treated by cryoablation.  To our knowledge,  this is the first case in Asia of 
RCC in a renal allograft treated using cryoablation.  Contrast-enhanced CT-guided percutaneous renal needle 
biopsy and cryoablation were used to identify the RCC,  which could not be identified by other techniques.  The 
postoperative course was uneventful.  Contrast-enhanced CT also showed no recurrence or metastases at the 
6-month follow-up.
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tion remained stable at 0.85 mg/dL.  In 2017,  a routine 
follow-up computerized tomography (CT) showed a 
20-mm lesion in the right native kidney and a 12-mm 
lesion in the renal allograft (Fig. 1).  The patient under-
went a laparoscopic radical nephrectomy of his right 
kidney,  with pathology demonstrating a type II papil-
lary renal cell carcinoma (Fig. 2A).  He was referred to 
our hospital for treatment of the renal tumor in the 
renal allograft.  The tumor was very small and com-
pletely endophytic,  making an ultrasound-guided renal 
needle biopsy impossible.  The patient therefore under-
went a contrast-enhanced CT-guided renal needle 
biopsy,  with pathology showing a RCC (Fig. 2B).  
However,  the tissue type could not be identified because 
the sample was too small.
Two months later,  the patient underwent con-
trast-enhanced CT-guided cryoablation under intrave-
nous sedation.  Two cryoprobes were placed under 
contrast-enhanced CT guidance.  Two 15-minute cycles 
of freezing and thawing were then performed 
(Fig. 3A , 3B).  Before cryoablation his serum creatinine 
was 0.88 mg/dL,  and LDH was 186 U/L,  while on 
postoperative day 1,  the serum creatinine had increased 
to 1.03 mg/dL and LDH to 518 U/L.  No complications 
developed,  and the patient’s serum creatinine level 
remained stable during the admission.  He was dis-
charged on postoperative day 5.  At the 6-month fol-
low-up,  his serum creatinine was 0.92 mg/dL and con-
trast-enhanced CT showed a 20-mm iceball with no 
enhancement,  indicating no recurrence of the tumor or 
presence of metastases (Fig. 4).
Discussion
This paper describes the first case in Asia of RCC in 
a renal allograft treated by cryoablation.  Contrast-
enhanced CT-guided percutaneous renal needle biopsy 
and cryoablation were used to identify and treat the 
RCC,  which could not be identified using other modal-
ities including ultrasound.
It has been reported that renal carcinomas make up 
4.6% of post-renal transplant cancers [1].  That study on 
7596 cases showed that the cancer developed in the dis-
eased kidney in 222 patients and in the allograft in 
24 patients [1].  The incidence of incidental renal cancer 
in a renal allograft is only 0.3% (24/7596);  this explains 
the rarity of our case report of cryoablation for RCC in 
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???? ?　 Contrast-enhanced CT image of the tumor (axial view):  
The white arrow shows a hypodense lesion at the upper pole of the 
renal allograft.
(A)
(B)
???? ?　 A,  Specimens by right nephrectomy: a type II papillary 
renal cell carcinoma showing papillary architecture with large,  
high-nuclear-grade cells; B,  Specimens obtained by contrast-en-
hanced CT guided renal needle biopsy: Atypical cells with papillary 
pattern were positive for CK7,  CD10,  AMACAR.  There was a 
possibility of its being papillary renal cell carcinoma,  but the spec-
imens were too small to identify the tissue type.
a renal allograft [1-4].  Ours is only the ninth such case 
in the world and the first case in Asia.  Patient sex,  age,  
tumor diameter,  guiding image,  and authors are detailed 
in Table 1 [2-5].
When there is the only functioning kidney in 
patients with a renal tumor,  it is important to attempt 
nephron-sparing treatment including partial nephrectomy,  
radiofrequency ablation,  and cryoablation.  Partial 
nephrectomy of a renal allograft is technically challeng-
ing because the renal hilum may be surrounded by des-
moplastic tissue.  The patients are also immunocom-
promised,  making their surgical risk considerably 
higher than that of immunocompetent patients.  A sys-
tematic review and meta-analysis of 3974 RCC patients,  
which are not only in a renal allograft,  demonstrated 
that compared with a partial nephrectomy,  thermal 
ablation including cryoablation showed no significant 
difference in local recurrence or metastases,  and was 
associated with a lower morbidity rate and a smaller 
reduction in eGFR [6].  Moreover,  the most recent 
report published in 2018 found no significant difference 
in complications,  renal function outcomes,  and onco-
logic outcomes between partial nephrectomy and per-
cutaneous cryoablation for patients with a tumor in a 
solitary kidney [7].  Radiofrequency ablation is a good 
treatment option;  however,  it is not approved by Japan’s 
national health insurance system.  Cryoablation is the 
only focal therapy for treatment of RCC approved by the 
national health insurance system in Japan.  Accordingly,  
our patient elected to undergo cryoablation.  If it is dif-
ficult to treat RCC with contrast-enhanced CT-guided 
cryoablation due to allergies to contrast medium or 
renal dysfunction,  MRI-guided cryoablation should be 
considered [3].
Our case had two different types of renal cancers,  
one in the right native kidney and the other in the renal 
allograft.  It would be interesting to know whether they 
arose from the same origin or were independent de novo 
cancers.  One case report showed metachronal RCC 
occurring in an allograft and a native kidney.  The 
researchers discovered that the donor was the origin of 
the RCC in the allograft while the origin of the RCC in 
the native kidney was not identified [8].  Unfortunately,  
our case did not undergo genetic examination of the 2 
tumors.  
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(A)
(B)
???? ?　 A,  Contrast-enhanced CT image of the tumor (axial 
view): The white arrow shows percutaneous cryoablation with con-
trast-enhanced CT; B,  Contrast-enhanced CT image of the tumor 
(coronal view): The white arrow shows 2 cryoprobes inserted into 
the tumor of the renal allograft.  
???? ?　 Six-month post-op: The white arrow shows a 20-mm ice-
ball with no enhancement after cryoablation.
Conclusion
We report the first case in Asia of RCC in a renal 
allograft treated by cryoablation.  Contrast-enhanced 
CT-guided cryoablation is a good technique for identi-
fying and treating small renal tumors that cannot be 
identified by other methods.
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Authors 
[Reference]
Published 
year Country
Sex/ 
Age 
(year)
Tomor  
Diameter 
(mm)
Guided  
image Histopathologic Findings
Shingleton,   
WB et.  al.  [3]
2002 USA M/81 15 MRI Clear cell carcinoma
Hruby,  GW  
et.  al.  [2]
2006 Columbia M/50 32 US Oncocytic neoplasm
Silvestri,  T 
et.  al.  [4]
2014 Italy F/88 13 CT Papillary carcinoma Type I
Cornelis,  F  
et.  al.  [5]
2011 One of  
France,   
Belgium,  
Italy,   
England,  
and USA
M/50 
F/55 
M/40 
F/37 
F/71
30 
35 
18 
20 
15
One of CT 
(3),  US(1),  
and  
CT/US(1)
Papillary carcinoma 
Clear cell carcinoma 
Papillary carcinoma 
Clear cell carcinoma 
Papillary carcinoma
Tsuboi,  I  
et.  al.
Present  
report
Japan M/61 12 CT Renal cell carcinoma,  (tissue 
type was not identiﬁed)
MRI,  magnetic resonance imaging US,  ultrasonography CT,  computed tomography.
